RGBD yields 57.85% · PFE yields 6.20%● Live data
📍 RGBD pulled ahead of the other in Year 1
Combined, RGBD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGBD + PFE for your $10,000?
Regional Brands Inc., through its subsidiaries, engages in the sale and distribution of windows, doors, and related hardware for use in commercial and residential buildings in the United States. It offers commercial windows, such as architectural aluminum, clad wood, fiberglass, composite, and diamond windows, as well as curtainwall and storefront products, interior fire rated glass and framing systems, and fiberglass reinforced entry door systems; and design development, budgeting, sample installation, energy surveys, prime contractor or subcontractor, bondable, complete submittal packages, installation, and other services. The company also distributes and installs commercial doors, frames, and hardware products, including wood doors, hollow metal doors and frames, locks, closers, exit devices, automatic operators, and other products. In addition, it supplies and installs specialty products comprising operable partitions, accordion doors, vertical folding walls, smoke and fire curtains, movable glass partition, and horizontal sliding fire doors, as well as repair services for its products. The company was formerly known as 4net Software, Inc. and changed its name to Regional Brands Inc. in May 2016. Regional Brands Inc. was founded in 1928 and is based in Mayfield Heights, Ohio.
Full RGBD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.